Literature DB >> 28067884

Reversal of pre-capillary pulmonary hypertension in a patient with sickle cell anemia who underwent haploidentical peripheral blood stem cell transplantation.

C Pittman1, M M Hsieh2, W Coles2, J F Tisdale2, N A Weir1, C D Fitzhugh1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28067884      PMCID： PMC6530467          DOI： 10.1038/bmt.2016.335

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes.

Authors:  Laura M De Castro; Jude C Jonassaint; Felicia L Graham; Allison Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

Review 2.  Pulmonary hypertension in sickle cell disease: diagnosis and management.

Authors:  Kenneth I Ataga; Elizabeth S Klings
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

3.  A hemodynamic study of pulmonary hypertension in sickle cell disease.

Authors:  Florence Parent; Dora Bachir; Jocelyn Inamo; François Lionnet; Françoise Driss; Gylna Loko; Anoosha Habibi; Soumiya Bennani; Laurent Savale; Serge Adnot; Bernard Maitre; Azzedine Yaïci; Leila Hajji; Dermot S O'Callaghan; Pierre Clerson; Robert Girot; Frederic Galacteros; Gerald Simonneau
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

4.  Mortality in adults with sickle cell disease and pulmonary hypertension.

Authors:  Alem Mehari; Mark T Gladwin; Xin Tian; Roberto F Machado; Gregory J Kato
Journal:  JAMA       Date:  2012-03-28       Impact factor: 56.272

5.  Pulmonary hypertension in sickle cell disease.

Authors:  Kenneth I Ataga; Namita Sood; Guy De Gent; Eileen Kelly; Ashley G Henderson; Susan Jones; Dell Strayhorn; Alice Lail; Susan Lieff; Eugene P Orringer
Journal:  Am J Med       Date:  2004-11-01       Impact factor: 4.965

6.  N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Authors:  Roberto F Machado; Anastasia Anthi; Martin H Steinberg; Duane Bonds; Vandana Sachdev; Gregory J Kato; Angelo M Taveira-DaSilva; Samir K Ballas; William Blackwelder; Xiuli Xu; Lori Hunter; Bruce Barton; Myron Waclawiw; Oswaldo Castro; Mark T Gladwin
Journal:  JAMA       Date:  2006-07-19       Impact factor: 56.272

7.  Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.

Authors:  Caterina P Minniti; Roberto F Machado; Wynona A Coles; Vandana Sachdev; Mark T Gladwin; Gregory J Kato
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

8.  Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency.

Authors:  Victor R Gordeuk; Vandana Sachdev; James G Taylor; Mark T Gladwin; Gregory Kato; Oswaldo L Castro
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

9.  Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival.

Authors:  Oswaldo Castro; Mohammed Hoque; Bernice D Brown
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245
  10 in total
  8 in total

1.  The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia.

Authors:  Courtney D Fitzhugh; Mark C Walters
Journal:  Blood Adv       Date:  2017-12-08

2.  Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell disease.

Authors:  Vandana Sachdev; Matthew Hsieh; Neal Jeffries; Anna Noreuil; Wen Li; Stanislav Sidenko; Hwaida Hannoush; Emily Limerick; Delon Wilson; John Tisdale; Courtney Fitzhugh
Journal:  Blood Adv       Date:  2019-10-08

Review 3.  Cardiovascular complications in patients with sickle cell disease.

Authors:  Mark T Gladwin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 4.  What is the role of screening for pulmonary hypertension in adults and children with sickle cell disease?

Authors:  Shaina M Willen; Mark T Gladwin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Pulmonary Manifestations of GATA2 Deficiency.

Authors:  Beatriz E Marciano; Kenneth N Olivier; Les R Folio; Christa S Zerbe; Amy P Hsu; Alexandra F Freeman; Armando C Filie; Michael A Spinner; Lauren A Sanchez; Jana P Lovell; Mark Parta; Jennifer M Cuellar-Rodriguez; Dennis D Hickstein; Steven M Holland
Journal:  Chest       Date:  2021-06-03       Impact factor: 10.262

6.  Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic Conditions.

Authors:  Tim Jang; George Mo; Connor Stewart; Leen Khoury; Natalie Ferguson; Ogechukwu Egini; John Muthu; Dibyendu Dutta; Moro Salifu; Seah H Lim
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 7.  Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.

Authors:  Andrew J Bryant; Borna Mehrad; Todd M Brusko; James D West; Lyle L Moldawer
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

Review 8.  Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease.

Authors:  Santosh L Saraf; Damiano Rondelli
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.